CXCR2 and esophageal squamous cell carcinoma: We noticed that CXCR2 inhibitor negatively affected esophageal cell proliferation while not affecting human dermis skin fibroblast (HDF) (Fig. S11), highlighting the importance of CXCR2 in ESCC, consistent with previous report (Wang et al., 2006).